All HEI'sAthlone Institute of TechnologyCork Institute of TechnologyDublin City UniversityDublin Institute of TechnologyMaynooth UniversityNational University of Ireland, GalwayRoyal College of SurgeonsTeagascTrinity College DublinUniversity College CorkUniversity College DublinUniversity of LimerickWaterford Institute of Technology All SectorsFuture Networks and CommunicationsData Analytics, Management, Security and PrivacyDigital Platforms, Content and ApplicationsConnected Health and Independent LivingMedical DevicesDiagnosticsTherapeutics - Synthesis, Formulation, Processing and Drug DeliveryFood for HealthSustainable Food Production and ProcessingMarine and Renewable EnergySmart Grids and Smart CitiesManufacturing CompetitivenessProcessing Technologies and Novel MaterialsInnovation in Services and Business ProcessesBreast Cancer Biomarkers as a Clinical Management Tool - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015Currently women diagnosed with breast cancer generally undergo surgery to remove the tumour. Many will also receive either chemo or radiotherapy or a combination of both. Approximately two thirds of all breast cancers ... pdf 375.9KBNovel companion diagnostic and treatment for metastic breast cancer disease - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015Endocrine therapies are the treatment of choice for over 70% of breast cancer patients, however 40% will relapse and develop metastatic disease. Metastasis is the prime cause of cancer patient mortality. There is curren... pdf 383.4KBOsteoporotic Bone Manipulating Device - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015A multi-disciplinary team of orthopaedic surgeons and engineers at the Royal College of Surgeons in Ireland have developed, patented and clinically tested a new Osteoporotic Bone Manipulator device that protects weak ost... pdf 219.5KBDiagnostic Biomarker Assay Maturity-Onset of Diabetes of the Young (MODY) - Licensing opportunity from Royal College of Surgeons in Ireland - November 2015The HNF1α-MODY diagnostic assay provides a new sensitive blood test that enables clinicians to more accurately identify cases of MODY and deliver the most appropriate treatment and prevent chronic diabetic complications ... pdf 218.4KBDose Response Medical Outcome Model Predictor System - licensing opportunity from Royal College of Surgeons in Ireland - November 2015 Aware of the need to personalise cancer treatment programmes in order to more effectively kill cancer cells while preserving healthy tissue, researchers at RCSI have developed a Dose Response Medical Outcome Model Predic... pdf 320.9KB First 1234567891011121314151617181920212223 Last Print Bookmark Top